Online citations, reference lists, and bibliographies.
← Back to Search

The Effect Of Topical Cyclosporin A On The Elicitation Phase Of Allergic Contact Dermatitis

G. W. Cole, S. Shimomaye, M. Goodman
Published 1988 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
The effect of cyclosporin A (CSA) on the elicitation phase of allergic contact dermatitis was investigated. Initially, the ability of CSA to penetrate normal human cadaver skin was determined using 3 different vehicles. 10% CSA in Labrafil was found to be the must effective combination at achieving skin penetration (0.33%). Patients with known contact sensitivities to a variety of allergens were selected. After a 48‐h pretreatment with 10% CSA in Labrafil, skin sites were exposed to the appropriate contact allergen. 72 h later, the development of an eczemutous patch test reaction was evaluated. Only 1 of 10 patients showed unequivocal signs of suppression of allergic contact dermatitis
This paper references

This paper is referenced by
Enhanced percutaneous absorption of a novel topical cyclosporin A formulation and assessment of its immunosuppressive activity
J. I. Duncan (1990)
Review of the pharmacokinetics, interactions and adverse reactions of cyclosporine in people, dogs and cats
D. Robson (2003)
Topical application of cyclosporine on guinea pig allergic contact dermatitis.
G. Lembo (1989)
Effect of Topical Preparation of Mycophenolic Acid on Experimental Allergic Contact Dermatitis of Guinea‐pigs Induced by Dinitrofluorobenzene
Y. Shôji (1994)
Effect of a new topical cyclosporin formulation on human allergic contact dermatitis
C. Surber (1992)
Cyclosporin A in the treatment of severe allergic contact dermatitis
Laura Flori (1993)
Getting the Dose Right in Dermatological Therapy
A. Davis (2007)
Topical cyclosporin A treatment in psoriasis and other dermatological diseases: Theoretical and practical aspects.
F. Heule (1992)
Prevention of nickel‐induced allergic contact reactions with pentoxifylline
H. Sarıcaoğlu (1998)
Dermatological Uses of Cyclosporin
J. A. Stutz (1995)
Novel cyclosporin derivatives featuring enhanced skin penetration despite increased molecular weight.
A. Billich (2005)
Patch‐Testing While on Systemic Immunosuppressants
D. Rosmarin (2009)
Iontophoresis of lecithin vesicles of cyclosporin A.
R. Boinpally (2004)
Evaluation of In‐vivo Transdermal Absorption of Cyclosporin with Absorption Enhancer Using Intradermal Microdialysis in Rats
M. Nakashima (1996)
Semantic Scholar Logo Some data provided by SemanticScholar